Transdermal Delivery of Cytochrome C—A 12.4 kDa Protein—Across Intact Skin by Constant–Current Iontophoresis
- First Online:
- 207 Downloads
To demonstrate the transdermal iontophoretic delivery of a small (12.4 kDa) protein across intact skin.
Materials and Methods
The iontophoretic transport of Cytochrome c (Cyt c) across porcine ear skin in vitro was investigated and quantified by HPLC. The effect of protein concentration (0.35 and 0.7 mM), current density (0.15, 0.3 or 0.5 mA.cm−2 applied for 8 h) and competing ions was evaluated. Co-iontophoresis of acetaminophen was employed to quantify the respective contributions of electromigration (EM) and electroosmosis (EO).
The data confirmed the transdermal iontophoretic delivery of intact Cyt c. Electromigration was the principal transport mechanism, accounting for ∼90% of delivery; correlation between EM flux and electrophoretic mobility was consistent with earlier results using small molecules. Modest EO inhibition was observed at 0.5 mA.cm−2. Cumulative permeation at 0.3 and 0.5 mA.cm−2 was significantly greater than that at 0.15 mA.cm−2; fluxes using 0.35 and 0.7 mM Cyt c in the absence of competing ions (Jtot = 182.8 ± 56.8 and 265.2 ± 149.1 μg.cm−2.h−1, respectively) were statistically equivalent. Formulation in PBS (pH 8.2) confirmed the impact of competing charge carriers; inclusion of ∼170 mM Na+ resulted in a 3.9-fold decrease in total flux.
Significant amounts (∼0.9 mg.cm−2 over 8 h) of Cyt c were delivered non-invasively across intact skin by transdermal electrotransport.
Key wordscytochrome c electromigration iontophoresis protein delivery skin permeation
- Cyt c
capillary zone electrophoresis
- JEM, Cyt c
flux due to electromigration of Cyt c
- JEO, Cyt c
flux due to electroosmosis of Cyt c
- Jtot, Cyt c
total steady-state flux of Cyt c
convective solvent flow
- 2.R. R. Burnette. Iontophoresis. In J. Hadgraft and R. Guy (eds.), Transdermal Drug Delivery, Marcel Dekker, New York, 1989, pp. 247–288.Google Scholar
- 13.R. Haak and S. K. Gupta. Pulsatile drug delivery from electrotransport therapeutic systems. In R. Gurny, H. E. Junginger, and N. A. Peppas (eds.), Pulsatile Drug Delivery—Current Applications and Future Trends, Wiss, Verl.-Ges., Stuttgart, 1993, pp. 99–112.Google Scholar
- 15.M. B. Delgado-Charro and R. H. Guy. Iontophoresis of peptides. In Bret Berner and S. M. Dinh (eds.), Electronically Controlled Drug Delivery, Vol. 1, CRS, New York, 1998, pp. 129–157.Google Scholar
- 23.J. E. De Muth. Basic Statistics and Pharmaceutical Statistical Applications, Marcel Dekker, New York, 1999.Google Scholar
- 29.W. H. M. Craane-van Hinsberg, L. Bax, N. H. M. Flinterman, J. Verhoef, H. E. Junginger, and H. E. Bodde. Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH and ionic strength on peptide flux and skin impedance. Pharm. Res. 11:1296–1300 (1994).PubMedCrossRefGoogle Scholar
- 30.M. F. Lu, D. Lee, R. Carlson, G. S. Rao, H. W. Hui, L. Adjei, M. Herrin, D. Sundberg, and L. Hsu. The effects of formulation variables on iontophoretic transdermal delivery of leuprolide to humans. Drug Deliv. Ind. Pharm. 19:1557–1571 (1993).Google Scholar